608 related articles for article (PubMed ID: 17558902)
1. Comorbidity and use of health-care services among irritable bowel syndrome sufferers.
Hillilä MT; Siivola MT; Färkkilä MA
Scand J Gastroenterol; 2007 Jul; 42(7):799-806. PubMed ID: 17558902
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.
Vandvik PO; Lydersen S; Farup PG
Scand J Gastroenterol; 2006 Jun; 41(6):650-6. PubMed ID: 16716962
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal complaints among subjects with depressive symptoms in the general population.
Hillilä MT; Hämäläinen J; Heikkinen ME; Färkkilä MA
Aliment Pharmacol Ther; 2008 Sep; 28(5):648-54. PubMed ID: 18564324
[TBL] [Abstract][Full Text] [Related]
4. Why do subjects with irritable bowel syndrome seek health care for their symptoms?
Ringström G; Abrahamsson H; Strid H; Simrén M
Scand J Gastroenterol; 2007 Oct; 42(10):1194-203. PubMed ID: 17852851
[TBL] [Abstract][Full Text] [Related]
5. Societal costs for irritable bowel syndrome--a population based study.
Hillilä MT; Färkkilä NJ; Färkkilä MA
Scand J Gastroenterol; 2010 May; 45(5):582-91. PubMed ID: 20166844
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity in irritable bowel syndrome.
Whitehead WE; Palsson OS; Levy RR; Feld AD; Turner M; Von Korff M
Am J Gastroenterol; 2007 Dec; 102(12):2767-76. PubMed ID: 17900326
[TBL] [Abstract][Full Text] [Related]
7. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study.
Lee S; Wu J; Ma YL; Tsang A; Guo WJ; Sung J
Aliment Pharmacol Ther; 2009 Sep; 30(6):643-51. PubMed ID: 19552631
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of irritable bowel syndrome: a community survey.
Wilson S; Roberts L; Roalfe A; Bridge P; Singh S
Br J Gen Pract; 2004 Jul; 54(504):495-502. PubMed ID: 15239910
[TBL] [Abstract][Full Text] [Related]
9. How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.
Johansson PA; Farup PG; Bracco A; Vandvik PO
BMC Gastroenterol; 2010 Mar; 10():31. PubMed ID: 20233451
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications.
Vandvik PO; Wilhelmsen I; Ihlebaek C; Farup PG
Aliment Pharmacol Ther; 2004 Nov; 20(10):1195-203. PubMed ID: 15569123
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
Hillilä MT; Färkkilä MA
Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
[TBL] [Abstract][Full Text] [Related]
14. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
15. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.
Schwille-Kiuntke J; Enck P; Zendler C; Krieg M; Polster AV; Klosterhalfen S; Autenrieth IB; Zipfel S; Frick JS
Neurogastroenterol Motil; 2011 Nov; 23(11):e479-88. PubMed ID: 21883703
[TBL] [Abstract][Full Text] [Related]
16. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
18. [An epidemiologic study of irritable bowel syndrome in Beijing - a stratified randomized study by clustering sampling].
Pan G; Lu S; Ke M; Han S; Guo H; Fang X
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Feb; 21(1):26-9. PubMed ID: 11860753
[TBL] [Abstract][Full Text] [Related]
19. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
Karling P; Danielsson A; Adolfsson R; Norrback KF
Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
[TBL] [Abstract][Full Text] [Related]
20. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study.
Morken MH; Lind RA; Valeur J; Wilhelmsen I; Berstad A
Scand J Gastroenterol; 2009; 44(3):308-13. PubMed ID: 19031266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
